BALORAMOTIDE
UNII 9T6PW6J6MA

Substance Identification & Data

This profile provides standardized clinical and technical data for Baloramotide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 9T6PW6J6MA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2207581-19-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
9T6PW6J6MA
CAS Registry Number
2207581-19-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BALORAMOTIDE
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C38143
National Cancer Institute reference terminology for clinical and research data.
INN ID
10983
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Baloramotide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BALORAMOTIDE

Common Names & Synonyms

AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, RECOMBINANT
BALORAMOTIDE [INN]
CANCER TESTIS ANTIGEN NY-ESO-1 (RECOMBINANT HUMAN)
CANCER/TESTIS ANTIGEN 1, RECOMBINANT
GLYCYL-L-PROLYL-HUMAN CANCER/TESTIS ANTIGEN 1 (AUTOIMMUNOGENIC CANCER/TESTIS ANTIGEN NY-ESO-1, L ANTIGEN FAMILY MEMBER 2 (LAGE-2), CANCER/TESTIS ANTIGEN 6.1, CT6.1)
L ANTIGEN FAMILY MEMBER 2, RECOMBINANT
LAGE-2, RECOMBINANT
RECOMBINANT NY-ESO-1 PROTEIN

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus